Europe Transfection Reagents And Equipment Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2023 –2030 |
 Market Size (Base Year) |
|
 Market Size (Forecast Year) |
|
 CAGR |
% |
| Major Markets Players |
>欧洲转染试剂和设备市场，按产品（试剂、试剂盒和仪器）、阶段（研究、临床前、临床阶段和商业）、类型（瞬时转染试剂和设备、稳定转染试剂和设备）、方法（非病毒方法和病毒方法）、分子类型（质粒 DNA、小干扰 RNA (siRNA)、蛋白质、DNA 寡核苷酸、核糖核蛋白复合物 (RNP) 等）、生物体（哺乳动物细胞、植物、真菌、病毒和细菌）、应用（体外应用、体内应用、生物生产等）、最终用户（生物制药、CRO、（CMO/CDMO）、学术界、医院、临床实验室等）、分销渠道（直接招标、零售等）、行业趋势和预测到 2030 年
欧洲转染试剂和设备市场分析与洞察
转染涉及通过病毒和非病毒方法将核酸引入真核细胞。转染方法可以克服转移带负电荷的膜的挑战。磷酸钙和二乙氨基乙基 (DEAE) 葡聚糖或阳离子脂质基试剂等化学物质与外部 DNA 外壳发生反应。它中和了整体负电荷，将正电荷赋予分子，从而允许 DNA 传递。电穿孔等物理方法通过施加电压在细胞膜上产生微小孔隙，允许 DNA 直接进入细胞质。DEAE-葡聚糖用于瞬时转染；然而，脂质转染可以实现稳定转染，因此可用于长期蛋白质表达。磷酸钙介导的转染也可用于稳定转染。病毒转染方法效率高，可用于药品开发的多个阶段。
转染方法用于农业的多种应用，包括保护作物和提高产量、生产合成生物产品以增强风味和香味、以及增强单细胞蛋白等。发达国家和发展中国家对转染的需求都在增加，其背后的原因是慢性病发病率的增加。由于对嵌合基因的需求不断增长以及生物制药在蛋白质生产中的利用，转染市场正在增长。由于新兴市场的探索、市场参与者的战略举措以及政府支持的增加，市场将在预测期内增长。
仪器的高成本、转染试剂的选择性有效性以及转染方法引起的细胞损伤预计会抑制欧洲转染试剂和设备市场的增长。
由于市场参与者采取了涉及收购、合作和伙伴关系的多项战略举措，市场正在不断增长。
Data Bridge Market Research分析，欧洲转染试剂和设备市场预计到2030年将达到513,494.89万美元的价值，预测期内的复合年增长率为8.6%。
|
报告指标 |
细节 |
|
预测期 |
2023 至 2030 年 |
|
基准年 |
2022 |
|
历史岁月 |
2021 (可定制为 2020-2016) |
|
定量单位 |
收入（千）、销量（个）、定价（美元） |
|
涵盖的领域 |
按产品（试剂和试剂盒及仪器）、阶段（研究、临床前、临床阶段和商业）、类型（瞬时转染试剂和设备、稳定转染试剂和设备）、方法（非病毒方法和病毒方法）、分子类型（质粒 DNA、小干扰 RNA (siRNA)、蛋白质、DNA 寡核苷酸、核糖核蛋白复合物 (RNP) 等）、生物体（哺乳动物细胞、植物、真菌、病毒和细菌）、应用（体外应用、体内应用、生物生产等）、最终用户（生物制药、CRO、（CMO/CDMO）、学术界、医院、临床实验室等）、分销渠道（直接招标、零售等）。 |
|
覆盖国家 |
德国、法国、意大利、英国、西班牙、瑞士、俄罗斯、荷兰、比利时、土耳其、欧洲其他国家。 |
|
涵盖的市场参与者 |
该市场的一些主要参与者包括 Mirus Bio LLC.、Promega Corporation、Polyplus Transfection、Bio-Rad Laboratories, Inc.、Merck KGaA、Lonza、MaxCyte, Inc.、Altogen Biosystems、SBS Genetech、FUJIFILM Irvine Scientific（FUJIFILM Holdings Corporation 的子公司）、Avanti Polar Lipids（Croda International Plc 的子公司）、PerkinElmer chemagen Technologie GmbH（PerkinElmer Inc. 的子公司）、Cytiva、Geno Technology Inc.、USA、R&D Systems, Inc.、Takara Bio Inc.、Thermofisher Scientific Inc.、Roche Molecular Systems, Inc.（F. Hoffmann-La Roche Ltd 的子公司）、QIAGEN、OriGene Technologies, Inc.、Applied Biological Materials Inc. (abm)、Beckman Coulter, Inc.（Danaher 的子公司）、Amyris、 Codexis、Autolus、SignaGen Laboratories、Impossible Foods Inc.、Genlantis Inc.、Ginkgo Bioworks、Verve Therapeutics, Inc.、Conagen, Inc.、Poseida Therapeutics, Inc. 和 Twist Bioscience 等。 |
市场定义
转染方法用于将RNA、DNA或蛋白质产物引入细胞，以改变生物体的表型和基因型。转染方法涉及新基因转移或转移基因构建体，例如成簇的规律间隔的短回文重复序列（CRISPR），用于基因组编辑目的。转染在免疫治疗、基因治疗和细胞治疗等领域有广泛的应用。转染包括非病毒和病毒介导的转染。化学和物理方法可以实现非病毒转染。用于转染的最常见化学方法是磷酸钙转染和脂质体转染等。病毒转染的转染效率高，用于转染的各种物理方法包括显微注射、基因枪粒子递送和电穿孔，其中电穿孔的转染效率高。转染有两种类型，可以是瞬时转染，也可以是稳定转染。对于基因敲除研究等短期基因表达研究，最好采用小规模生产的瞬时转染方法；但长期研究和大规模蛋白质生产的稳定转染方法被广泛采用。
欧洲转染试剂和设备市场动态
本节旨在了解市场驱动因素、优势、机遇、限制和挑战。下面将详细讨论所有这些内容：
驱动程序
- 慢性病患病率上升
全球范围内慢性病的发病率不断上升，因此需要有效而精准的治疗。转染用于递送靶向修饰基因，以治疗多种遗传疾病。转染方法还用于递送 CRISPR 基因，该基因可增强适应性免疫力并预防个体患上各种疾病。
新冠肺炎等慢性病和其他传染病病例的增加，促使人们发现了有效的基因治疗产品，这些产品可以用正确的基因取代有缺陷的基因。转染方法被广泛用于基因治疗等。随着全球对有效和准确治疗的需求不断增加，对基因治疗和转染方法的需求也在增加。此外，几项正在进行的研究证明基因疗法具有治疗慢性病的潜力，这也增加了医生和患者对基因疗法的需求。这意味着慢性病患病率的上升正在成为欧洲转染试剂和设备市场增长的驱动力。
- 合成生物产品的开发
合成生物学是将工程原理融入生物学的新时代。合成生物学涉及 DNA 的化学合成，结合基因组学知识重新组装 DNA 基因组。将序列化成新基因的合成生物学涉及基因工程，其中包括转染方法等。随着全球对合成生物学产品的需求不断增加，转染产品的使用也越来越多。
由于对有效和创新产品的需求不断增加，对合成生物学产品的需求也在增加。合成产品的制造增加了对转染产品的需求，因为基因转移可以伴随转染方法等。因此，这意味着合成产品开发推动了欧洲转染试剂和设备市场的增长。
克制
- 转染过程引起的细胞损伤
据报道，有些转染方法会造成细胞损伤，从而降低整个方法的可重复性。在几种转染方法中，据报道，电穿孔会随着电压的增加而造成最大的细胞损伤。这种细胞损伤会降低效率并影响正在进行的项目。
转染程序最常见的副作用之一是细胞损伤，这会降低细胞代谢事件并导致细胞死亡。这种受损细胞会增强培养基毒性，从而产生不适当的结果。因此，这表明转染程序引起的细胞损伤会限制欧洲转染试剂和设备市场的增长。
机会
-
探索新兴市场
转染产品已被证明是基因工程和蛋白质组学行业的有前途的工具。转染产品的最大市场是欧洲和北美。通过观察这些产品的积极成果，许多市场参与者正在扎根于包括中国和印度在内的发展中经济体。新兴市场使这些市场参与者能够应对成熟市场带来的损失。
由于新兴市场使市场参与者能够克服特定成熟市场特有的经济衰退，因此新兴市场的投资和探索使市场参与者能够参与转染产品的开发和制造，从而实现丰厚的增长。因此，这意味着探索新兴市场是发展欧洲转染试剂和设备市场的机会。
挑战
- 漫长的审批程序
转染试剂和仪器的审批程序冗长，阻碍了转染市场的发展。转染产品受到严格的监管，每次都必须监控。转染产品广泛用于将所需基因分子插入特定细胞系以获取蛋白质和其他生物化合物。因此，该过程需要经过漫长而严格的监管程序进行审查和批准。每次临床试验都需要漫长的过程才能获得积极的结果，这导致市场参与者耗费更多时间并投入大量资金。
转染试剂主要受 21CFR 第 210 和 211 部分美国 FDA 指南的约束，根据该指南，制造商必须确保所生产的试剂符合监管机构提出的安全、包装和加工特性。所有者或制造商必须根据 PHS（公共卫生服务）法案第 351 条提交许可证，这是一个相当繁琐的过程。因此，这意味着漫长的审批程序对欧洲转染试剂和设备市场的增长构成了挑战。
最新动态
- 2021 年 8 月，Mirus Bio 扩展了 TransIT VirusGen 平台，使其符合良好生产规范 (GMP) 病毒载体生产标准，以支持细胞和基因疗法的开发、工艺操作和商业生产。该扩展称为 TransIT VirusGen GMP 转染试剂，旨在改善载体 DNA 的包装和输送到悬浮和粘附 HEK 293 细胞类型，从而改善重组腺相关病毒和慢病毒载体的生产。
- 2021年4月，BOC Sciences宣布推出两款体内RNA转染试剂盒，分别为siRNA体内转染试剂盒和mRNA体内转染试剂盒，分别适用于siRNA和mRNA的体内转染。
欧洲转染试剂和设备市场范围
欧洲转染试剂和设备市场分为九个显著的细分市场，例如产品、阶段、方法、类型、分子类型、应用、最终用户、生物体和分销渠道。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略，并确定您的核心应用领域和目标市场的差异。
产品
- 乐器
- 试剂与试剂盒
根据产品，欧洲转染试剂和设备市场分为仪器和试剂及试剂盒。
阶段
- 研究
- 临床前
- 临床阶段
- 商业的
根据阶段，欧洲转染试剂和设备市场分为研究、临床前、临床阶段和商业。
类型
- 瞬时转染试剂和设备
- 稳定的转染试剂和设备
根据类型，欧洲转染试剂和设备市场分为瞬时转染试剂和设备以及稳定转染试剂和设备。
方法
- 非病毒方法
- 病毒方法
根据方法，欧洲转染试剂和设备市场分为非病毒方法和病毒方法。
分子类型
- 质粒DNA
- DNA寡核苷酸
- 小干扰RNA（SIRNA）
- 蛋白质
- 核糖核蛋白复合物 (RNPS)
- 其他的
根据分子类型，欧洲转染试剂和设备市场分为质粒 DNA、DNA 寡核苷酸、小干扰 RNA (siRNA)、蛋白质、核糖核蛋白复合物 (RNP) 和其他。
生物
- 细菌
- 哺乳动物细胞
- 真菌
- 植物
- 病毒
根据生物体，欧洲转染试剂和设备市场分为细菌、哺乳动物细胞、真菌、植物和病毒。
应用
- 按类型
- 体外应用
- 体内应用
- 生物生产
- 其他的
- 按行业
- 农业
- 合成生物学
- 其他的
根据应用，欧洲转染试剂和设备市场按类型细分为体外应用、体内应用、生物生产和其他，按行业细分为农业、合成生物学和其他。
最终用户
- 生物制药
- 克罗斯
- CMOS/CDMOS
- 学术界
- 医院
- 临床实验室
- 其他的
根据最终用户，欧洲转染试剂和设备市场分为生物制药、CRO、CMO/CDMO、学术界、医院、临床实验室和其他。
分销渠道
- 直接招标
- 零售销售
- 其他的
根据分销渠道，欧洲转染试剂和设备市场分为直接招标、零售和其他。
欧洲转染试剂和设备市场区域分析/见解
欧洲转染试剂和设备市场分为许多显著的部分，如地理、产品、阶段、方法、类型、分子类型、应用、最终用户、生物体和分销渠道。
本市场报告涵盖的国家包括德国、法国、意大利、英国、西班牙、瑞士、俄罗斯、荷兰、比利时、土耳其和欧洲其他地区。
2023 年，由于新兴市场需求的增加和扩张，德国将在欧洲地区占据主导地位。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外，在对国家数据进行预测分析时，还考虑了欧洲品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀少竞争而面临的挑战，以及销售渠道的影响。
竞争格局和欧洲转染试剂和设备市场份额分析
欧洲转染试剂和设备市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品批准、产品宽度和广度、应用优势、产品类型生命线曲线。以上提供的数据点仅与公司对欧洲转染试剂和设备市场的关注有关。
该市场的一些主要参与者包括 Mirus Bio LLC.、Promega Corporation、Polyplus Transfection、Bio-Rad Laboratories, Inc.、Merck KGaA、Lonza、MaxCyte, Inc.、Altogen Biosystems、SBS Genetech、FUJIFILM Irvine Scientific（FUJIFILM Holdings Corporation 的子公司）、Avanti Polar Lipids（Croda International Plc 的子公司）、PerkinElmer chemagen Technologie GmbH（PerkinElmer Inc. 的子公司）、Cytiva、Geno Technology Inc.、USA、R&D Systems, Inc.、Takara Bio Inc.、Thermofisher Scientific Inc.、Roche Molecular Systems, Inc.（F. Hoffmann-La Roche Ltd 的子公司）、QIAGEN、OriGene Technologies, Inc.、Applied Biological Materials Inc. (abm)、Beckman Coulter, Inc.（Danaher 的子公司）、Amyris、 Codexis、Autolus、SignaGen Laboratories、Impossible Foods Inc.、Genlantis Inc.、Ginkgo Bioworks、Verve Therapeutics, Inc.、Conagen, Inc.、Poseida Therapeutics, Inc. 和 Twist Bioscience 等。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 TRANSIENT TRANSFECTION OF TRANSFECTION LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHT
4.1 PESTEL
4.2 PORTER'S FIVE FORCES MODEL
5 INDUSTRY INSIGHTS:
6 EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET, REGULATIONS
6.1 EUROPEAN UNION REGULATORY SCENARIO
6.2 U.S. REGULATORY SCENARIO
6.3 JAPAN REGULATORY SCENARIO
6.4 CHINA REGULATORY SCENARIO
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 RISE IN THE PREVALENCE OF CHRONIC DISEASES
7.1.2 DEVELOPMENT OF SYNTHETIC BIOLOGY PRODUCTS
7.1.3 GROWING DEMAND FOR CHIMERIC GENES
7.1.4 LARGE-SCALE TRANSFECTIONS USED IN CLINICAL RESEARCH
7.1.5 UTILIZATION OF BIOPHARMACEUTICALS IN THE PRODUCTION OF PROTEINS
7.2 RESTRAINTS
7.2.1 HIGH COST OF TRANSFECTION PRODUCTS
7.2.2 SELECTIVE EFFECTIVENESS OF TRANSFECTION REAGENTS
7.2.3 CELL DAMAGE INDUCED BY TRANSFECTION PROCEDURE
7.3 OPPORTUNITIES
7.3.1 EXPLORATION OF EMERGING MARKET
7.3.2 STRATEGIC INITIATIVES BY MARKET PLAYERS
7.3.3 SURGING LEVEL OF INVESTMENT
7.4 CHALLENGES
7.4.1 LONG APPROVAL PROCEDURE
7.4.2 LACK OF SAFETY LEVEL LAB FOR VIRUS-ASSOCIATED TRANSFECTION
7.4.3 LACK OF TRAINED PROFESSIONALS
8 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY PRODUCTS
8.1 OVERVIEW
8.2 REAGENTS & KITS
8.3 INSTRUMENTS
9 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY STAGE
9.1 OVERVIEW
9.2 RESEARCH
9.3 PRECLINICAL
9.4 CLINICAL PHASES
9.5 COMMERCIAL
10 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY TYPE
10.1 OVERVIEW
10.2 TRANSIENT TRANSFECTION REAGENTS AND EQUIPMENT
10.3 STABLE TRANSECTION REAGENTS AND EQUIPMENT
11 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY METHODS
11.1 OVERVIEW
11.2 NON-VIRAL METHODS
11.3 VIRAL METHODS
12 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY TYPES OF MOLECULE
12.1 OVERVIEW
12.2 PLASMID DNA
12.3 SMALL INTERFERING RNA (SIRNA)
12.4 PROTEINS
12.5 DNA OLIGONUCLEOTIDES
12.6 RIBONUCLEOPROTEIN COMPLEXES (RNPS)
12.7 OTHERS
13 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY ORGANISM
13.1 OVERVIEW
13.2 MAMMALIAN CELLS
13.3 PLANTS
13.4 FUNGI
13.5 VIRUS
13.6 BACTERIA
14 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY APPLICATION
14.1 OVERVIEW
14.2 IN VITRO APPLICATION
14.2.1 IN VIVO APPLICATION
14.2.2 BIOPRODUCTION
14.2.3 OTHERS
14.2.4 SYNTHETIC BIOLOGY
14.2.5 AGRICULTURE
14.2.6 OTHERS
15 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY END USER
15.1 OVERVIEW
15.2 BIOPHARMA
15.3 CROS
15.4 CMOS/CDMOS
15.5 ACADEMIA
15.6 HOSPITALS
15.7 CLINICAL LABS
15.8 OTHERS
16 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL
16.1 OVERVIEW
16.2 DIRECT TENDER
16.3 RETAIL SALES
16.4 OTHERS
17 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION
17.1 EUROPE
17.1.1 GERMANY
17.1.2 U.K.
17.1.3 FRANCE
17.1.4 ITALY
17.1.5 RUSSIA
17.1.6 SPAIN
17.1.7 TURKEY
17.1.8 NETHERLANDS
17.1.9 BELGIUM
17.1.10 SWITZERLAND
17.1.11 REST OF EUROPE
18 EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET, COMPANY LANDSCAPE
18.1 COMPANY SHARE ANALYSIS: EUROPE
19 SWOT ANALYSIS
20 COMPANY PROFILE
20.1 THERMO FISHER SCIENTIFIC INC.
20.1.1 COMPANY SNAPSHOT
20.1.2 REVENUE ANALYSIS
20.1.3 COMPANY SHARE ANALYSIS
20.1.4 PRODUCT PORTFOLIO
20.1.5 RECENT DEVELOPMENT
20.2 ROCHE MOLECULAR SYSTEMS, INC. (A SUBSIDIARY OF F. HOFFMANN-LA ROCHE LTD)
20.2.1 COMPANY SNAPSHOT
20.2.2 REVENUE ANALYSIS
20.2.3 COMPANY SHARE ANALYSIS
20.2.4 PRODUCT PORTFOLIO
20.2.5 RECENT DEVELOPMENT
20.3 PROMEGA CORPORATION
20.3.1 COMPANY SNAPSHOT
20.3.2 COMPANY SHARE ANALYSIS
20.3.3 PRODUCT PORTFOLIO
20.3.4 RECENT DEVELOPMENT
20.4 TAKARA BIO INC.
20.4.1 COMPANY SNAPSHOT
20.4.2 REVENUE ANALYSIS
20.4.3 COMPANY SHARE ANALYSIS
20.4.4 PRODUCT PORTFOLIO
20.4.5 RECENT DEVELOPMENT
20.5 BIO-RAD LABORATORIES, INC.
20.5.1 COMPANY SNAPSHOT
20.5.2 REVENUE ANANLYSIS
20.5.3 COMPANY SHARE ANALYSIS
20.5.4 PRODUCT PORTFOLIO
20.5.5 RECENT DEVELOPMENT
20.6 ALTOGEN BIOSYSTEMS
20.6.1 COMPANY SNAPSHOT
20.6.2 PRODUCT PORTFOLIO
20.6.3 RECENT DEVELOPMENT
20.7 APPLIED BIOLOGICAL MATERIALS INC. (ABM)
20.7.1 COMPANY SNAPSHOT
20.7.2 PRODUCT PORTFOLIO
20.7.3 RECENT DEVELOPMENT
20.8 AVANTI POLAR LIPIDS (A SUBSIDIARY OF CRODA INTERNATIONAL PLC)
20.8.1 COMPANY SNAPSHOT
20.8.2 REVENUE ANALYSIS
20.8.3 PRODUCT PORTFOLIO
20.8.4 RECENT DEVELOPMENT
20.9 BECKMAN COULTER, INC. (A SUBSIDIARY OF DANAHER)
20.9.1 COMPANY SNAPSHOT
20.9.2 PRODUCT PORTFOLIO
20.9.3 RECENT DEVELOPMENT
20.1 CYTIVA
20.10.1 COMPANY SNAPSHOT
20.10.2 PRODUCT PORTFOLIO
20.10.3 RECENT DEVELOPMENT
20.11 FUJIFILM IRVINE SCIENTIFIC (A SUBSIDIARY OF FUJIFILM HOLDINGS CORPORATION)
20.11.1 COMPANY SNAPSHOT
20.11.2 REVENUE ANANLYSIS
20.11.3 PRODUCT PORTFOLIO
20.11.4 RECENT DEVELOPMENT
20.12 GENLANTIS INC.
20.12.1 COMPANY SNAPSHOT
20.12.2 PRODUCT PORTFOLIO
20.12.3 RECENT DEVELOPMENT
20.13 GENO TECHNOLOGY INC., USA
20.13.1 COMPANY SNAPSHOT
20.13.2 PRODUCT PORTFOLIO
20.13.3 RECENT DEVELOPMENT
20.14 GINKGO BIOWORKS
20.14.1 COMPANY SNAPSHOT
20.14.2 PRODUCT PORTFOLIO
20.14.3 RECENT DEVELOPMENTS
20.15 LONZA
20.15.1 COMPANY SNAPSHOT
20.15.2 REVENUE ANANLYSIS
20.15.3 PRODUCT PORTFOLIO
20.15.4 RECENT DEVELOPMENT
20.16 MAXCYTE, INC.
20.16.1 COMPANY SNAPSHOT
20.16.2 REVENUE ANALYSIS
20.16.3 PRODUCT PORTFOLIO
20.16.4 RECENT DEVELOPMENT
20.17 MERCK KGAA
20.17.1 COMPANY SNAPSHOT
20.17.2 REVENUE ANALYSIS
20.17.3 PRODUCT PORTFOLIO
20.17.4 RECENT DEVELOPMENT
20.18 MIRUS BIO LLC.
20.18.1 COMPANY SNAPSHOT
20.18.2 PRODUCT PORTFOLIO
20.18.3 RECENT DEVELOPMENT
20.19 ORIGENE TECHNOLOGIES, INC.
20.19.1 COMPANY SNAPSHOT
20.19.2 PRODUCT PORTFOLIO
20.19.3 RECENT DEVELOPMENT
20.2 PERKINELMER CHEMAGEN TECHNOLOGIE GMBH (A SUBSIDIARY OF PERKINELMER INC.)
20.20.1 COMPANY SNAPSHOT
20.20.2 REVENUE ANALYSIS
20.20.3 PRODUCT PORTFOLIO
20.20.4 RECENT DEVELOPMENT
20.21 POLYPLUS TRANSFECTION
20.21.1 COMPANY SNAPSHOT
20.21.2 PRODUCT PORTFOLIO
20.21.3 RECENT DEVELOPMENT
20.22 R&D SYSTEMS, INC.
20.22.1 COMPANY SNAPSHOT
20.22.2 PRODUCT PORTFOLIO
20.22.3 RECENT DEVELOPMENT
20.23 SBS GENETECH
20.23.1 COMPANY SNAPSHOT
20.23.2 PRODUCT PORTFOLIO
20.23.3 RECENT DEVELOPMENT
20.24 SIGNAGEN LABORATORIES
20.24.1 COMPANY SNAPSHOT
20.24.2 PRODUCT PORTFOLIO
20.24.3 RECENT DEVELOPMENT
21 QUESTIONNAIRE
22 RELATED REPORTS
表格列表
TABLE 1 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY PRODUCTS, 2021-2030 (USD THOUSAND)
TABLE 2 EUROPE REAGENT AND KITS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 3 EUROPE INSTRUMENTS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 4 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY STAGE, 2021-2030 (USD THOUSAND)
TABLE 5 EUROPE RESEARCH IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 6 EUROPE PRECLINICAL IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 7 EUROPE CLINICAL PHASES IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 8 EUROPE COMMERCIAL IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 9 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 10 EUROPE TRANSIENT TRANSFECTION REAGENTS AND EQUIPMENT IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 11 EUROPE STABLE TRANSFECTION REAGENTS AND EQUIPMENT IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 12 EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY METHODS, 2021-2030 (USD THOUSAND)
TABLE 13 EUROPE NON-VIRAL METHODS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 14 EUROPE VIRAL METHODS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 15 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY TYPES OF MOLECULE, 2021-2030 (USD THOUSAND)
TABLE 16 EUROPE PLASMID DNA IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 17 EUROPE SMALL INTERFERING RNA (SIRNA) IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 18 EUROPE PROTEINS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 19 EUROPE DNA OLIGONUCLEOTIDES IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 20 EUROPE RIBONUCLEOPROTEIN COMPLEXES (RNPS) IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 21 EUROPE OTHERS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 22 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY ORGANISM, 2021-2030 (USD THOUSAND)
TABLE 23 EUROPE MAMMALIAN CELLS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 24 EUROPE PLANTS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 25 EUROPE FUNGI IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 26 EUROPE VIRUS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 27 EUROPE BACTERIA IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 28 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET , BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 29 EUROPE IN VITRO APPLICATION IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 30 EUROPE IN VIVO APPLICATION IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 31 EUROPE BIOPRODUCTION IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 32 EUROPE OTHERS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 33 EUROPE APPLICATION IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY INDUSTRY, 2021-2030 (USD THOUSAND)
TABLE 34 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 35 EUROPE BIOPHARMA IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 36 EUROPE CROS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 37 EUROPE CMOS/CDMOS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 38 EUROPE ACADEMIA IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 39 EUROPE HOSPITALS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 40 EUROPE CLINICAL LABS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 41 EUROPE OTHERS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 42 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 43 EUROPE DIRECT TENDER IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 44 EUROPE RETAIL SALES IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 45 EUROPE OTHERS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
图片列表
FIGURE 1 EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET: SEGMENTATION
FIGURE 2 EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET: DROC ANALYSIS
FIGURE 4 EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET: EUROPE VS REGIONAL MARKET ANALYSIS
FIGURE 5 EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET: MULTIVARIATE MODELLING
FIGURE 7 EUROPE TRANSFECTION MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET: DBMR MARKET POSITION GRID
FIGURE 9 EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 10 EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET: VENDOR SHARE ANALYSIS
FIGURE 11 EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET: SEGMENTATION
FIGURE 12 INCREASING OCCURENCE OF CHRONIC DISEASES AND DEVELOPMENT OF SYNTHETIC BIOLOGY PRODUCTS IS DRIVING THE EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET IN THE FORECAST PERIOD OF 2022 TO 2030
FIGURE 13 THE TRANSIENT TRANSFECTION SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET IN 2022 & 2030
FIGURE 14 APPROVAL PROCESS FOR GENE THERAPY IN CHINA
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET
FIGURE 16 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY PRODUCTS, 2023
FIGURE 17 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY PRODUCTS, 2023-2030 (USD THOUSAND)
FIGURE 18 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY PRODUCTS, CAGR (2023-2030)
FIGURE 19 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY PRODUCTS, LIFELINE CURVE
FIGURE 20 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY STAGE, 2023
FIGURE 21 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY STAGE, 2023-2030 (USD THOUSAND)
FIGURE 22 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY STAGE, CAGR (2023-2030)
FIGURE 23 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY STAGE, LIFELINE CURVE
FIGURE 24 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY TYPE, 2023
FIGURE 25 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY TYPE, 2023-2030 (USD THOUSAND)
FIGURE 26 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY TYPE, CAGR (2023-2030)
FIGURE 27 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY TYPE, LIFELINE CURVE
FIGURE 28 EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET: BY METHODS, 2022
FIGURE 29 EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET: BY METHODS, 2023-2030 (USD THOUSAND)
FIGURE 30 EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET: BY METHODS, CAGR (2023-2030)
FIGURE 31 EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET: BY METHODS, LIFELINE CURVE
FIGURE 32 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY TYPES OF MOLECULE, 2022
FIGURE 33 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY TYPES OF MOLECULE, 2023-2030 (USD THOUSAND)
FIGURE 34 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY TYPES OF MOLECULE, CAGR (2023-2030)
FIGURE 35 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY TYPES OF MOLECULE, LIFELINE CURVE
FIGURE 36 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY ORGANISM, 2022
FIGURE 37 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY ORGANISM, 2023-2030 (USD THOUSAND)
FIGURE 38 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY ORGANISM, CAGR (2023-2030)
FIGURE 39 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY ORGANISM, LIFELINE CURVE
FIGURE 40 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET BY APPLICATION, 2022
FIGURE 41 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET BY APPLICATION, 2023-2030 (USD THOUSAND)
FIGURE 42 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET BY APPLICATION, CAGR (2023-2030)
FIGURE 43 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET BY APPLICATION, LIFELINE CURVE
FIGURE 44 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY END USER, 2022
FIGURE 45 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET : BY END USER, 2023-2030 (USD THOUSAND)
FIGURE 46 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET : BY END USER, CAGR (2023-2030)
FIGURE 47 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET : BY END USER, LIFELINE CURVE
FIGURE 48 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 49 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD THOUSAND)
FIGURE 50 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 51 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 52 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: SNAPSHOT (2022)
FIGURE 53 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY COUNTRY (2022)
FIGURE 54 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY COUNTRY (2023 & 2030)
FIGURE 55 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY COUNTRY (202 & 2030)
FIGURE 56 EUROPE TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY PRODUCTS (2023-2030)
FIGURE 57 EUROPE TRANSFECTION REAGENTS AND EQUIPMENT MARKET: COMPANY SHARE 2022 (%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
